Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aldeyra Therapeu (NQ: ALDX )

13.37 USD +1.18 (+9.68%)
Official Closing Price Updated: 6:55 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aldeyra Therapeu

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
3 Biotech Stocks That Jumped Last Week
Find out what led to the biotech industry's biggest gains. 
Tags ALDX LXRX NCNA
From Motley Fool
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
Insider buying can be an encouraging signal for investors, particularly when there is uncertainty in the markets, as there has been due to the pandemic and political issues. Here are some insider... 
Tags Stocks / Equities
From Blogs - TalkMarkets
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders were taking ... 
Tags YORW Aldeyra Therapeutics REV Group
From Benzinga
Stocks That Hit 52-Week Highs On Friday
This morning 150 companies reached new 52-week highs. Interesting Points: Eli Lilly (NYSE:LLY) was the largest firm ... 
Tags REKR GRNV News
From Benzinga
70 Biggest Movers From Yesterday
Gainers Poshmark, Inc. (NASDAQ: POSH) shares climbed 141.7% to close at $101.50 on Thursday as the company priced its IPO at $42 ... 
Tags NPA BNR Markets
From Benzinga
Why Aldeyra Therapeutics Stock Is Jumping Today
The company announced the pricing of a public stock offering. 
Tags Market News ALDX
From Motley Fool
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Market News KOD BCAB
From Benzinga
Aldeyra Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with... 
From Business Wire News Releases
Aldeyra Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with... 
From Business Wire News Releases
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FUSN BHC IBB
From Benzinga
Thinking about buying stock in T2 Biosystems, Zomedica, Aldeyra Therapeutics, La Jolla Pharmaceutical, or US Well Services?
InvestorsObserver issues critical PriceWatch Alerts for TTOO, ZOM, ALDX, LJPC, and USWS. 
From PR Newswire
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags JNJ MRK EYEN
From Benzinga
82 Biggest Movers From Friday
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 177% to close at $2.13on Friday after the company announced ... 
Tags MRUS BRPA NM
From Benzinga
Aldeyra Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BioConnect 2021 Virtual Conference
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright... 
From Business Wire News Releases
95 Biggest Movers From Yesterday
Gainers Future FinTech Group Inc. (NASDAQ: FTFT) shares climbed 242.3% to close at $5.75 on Thursday as the company said China ... 
Tags Movers NCTY MTLS
From Benzinga
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SGMO MOR Small Cap
From Benzinga
Aldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced positive top-line symptom, redness, and Schirmer’s test results from the run-in cohort of the Phase 3 TRANQUILITY clinical trial in... 
From Business Wire News Releases
Aldeyra Therapeutics to Host Conference Call and Webcast to Discuss Top-Line Symptom, Redness, and Schirmer’s Test Results from Run-in Cohort of Phase 3 TRANQUILITY Trial
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Thursday, January 7, 2021, to discuss top-line symptom, redness, and Schirmer’s test results... 
From Business Wire News Releases
Aldeyra Therapeutics Announces Confirmation of Antiviral Activity of ADX-1612
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced confirmation of SARS-CoV-2 antiviral activity of ADX-1612, in addition to novel anti-inflammatory activity in SARS-CoV-2-infected... 
From Business Wire News Releases
Aldeyra Therapeutics Announces Initiation of Phase 2 Clinical Trials of ADX-629, a First-in-Class Orally Administered RASP Inhibitor, for the Treatment of COVID-19, Atopic Asthma, and Psoriasis
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the initiation of Phase 2 clinical trials of ADX-629, a first-in-class orally administered reactive aldehyde species (RASP)... 
From Business Wire News Releases
Benzinga's Top Upgrades, Downgrades For December 16, 2020
Upgrades For Amplify Energy Corp (NYSE: AMPY), Roth Capital upgraded the previous rating of Neutral to the current rating Buy. For ... 
Tags SAVE HAIN PANW
From Benzinga
Analysts Forecast 15% Gains Ahead For The Holdings of PTH
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aldeyra Announces First Patient Enrolled in the Phase 3 TRANQUILITY Trial of Reproxalap for the Treatment of Dry Eye Disease
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with... 
From Business Wire News Releases
Aldeyra Therapeutics to Participate in the Jefferies and A.G.P./Alliance Global Partners Virtual Investor Conferences
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the company’s senior management will participate in the following virtual investor conferences: 
From Business Wire News Releases
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Benzinga OCUL ORIC
From Benzinga
How The Parts Add Up: DWAS Headed For $75
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags NKTR PRAX ATHX
From Benzinga
Aldeyra Therapeutics Announces Third-Quarter 2020 Financial Results and Provides Corporate Update
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with... 
From Business Wire News Releases
Aldeyra to Participate in the American Academy of Ophthalmology Eyecelerator 2020 Virtual Conference on Friday, November 6
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and CEO Todd C. Brady, M.D., Ph.D., will discuss Aldeyra’s novel therapeutic approaches to treating anterior and... 
From Business Wire News Releases
Aldeyra Has 'Catalayst-Rich' 12 Months Ahead, Jefferies Says In Bullish Initiation
Shares of Aldeyra Therapeutics Inc (NASDAQ: ALDX), a company focusing on immune-mediated diseases, are primed for further upside, ... 
Tags Analyst Ratings Analyst Color Kelly Shi
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.